Drug Discount Program: Update on Agency Efforts to Improve 340B Program Oversight
Testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives, describing the Health Resources and Services Administration's (HRSA) actions and plans for improving 340B program oversight. Also provides an update on the Government Accountability Office's work regarding the 340B program and HRSA oversight. Includes information on 340B program participants, background, structure, audit frequency, and more.
Government Accountability Office
Medicaid · Pharmacy and prescription drugs · Policy